Abstract

FIERRO-MACIAS, Alfonso Eduardo et al. Association between IGF system and PAPP-A in coronary atherosclerosis. Arch. Cardiol. Méx. [online]. 2016, vol.86, n.2, pp.148-156. ISSN 1665-1731.  https://doi.org/10.1016/j.acmx.2015.12.006.

Atherosclerosis is a condition that involves multiple pathophysiological mechanisms and whose knowledge has not been fully elucidated. Often, scientific advances on the atherogenic pathophysiology generate that molecules not previously considered in the scene of this disease, were attributed actions on the onset or progression of it. A representative example is the study of a new mechanism involved in the atherogenic process, consisting of the association between the insulin-like growth factor (IGF) system and pregnancy-associated plasma protein-A (PAPP-A). Insulin-like growth factor system is a family of peptides that include 3 peptide hormones, 4 transmembrane receptors and 6 binding proteins. Insulin-like growth factor-1 (IGF-1) is the main ligand of the IGF system involved in coronary atherosclerosis. IGF-1 exerts its effects via activation of the IGF-1R receptor on vascular smooth muscle cells or macrophages. In vascular smooth muscle cells promotes migration and prevents apoptosis which increases plaque stability while in macrophages reduces reverse cholesterol transport leading to the formation of foam cells. Regulation of IGF-1 endothelial bioavailability is carried out by IGFBP proteases, mainly by PAPP-A. In this review, we address the mechanisms between IGF system and PAPP-A in atherosclerosis with emphasis on molecular effects on vascular smooth muscle cells and macrophages.

Keywords : Insulin-like growth factor system; Pregnancy-associated plasma protein-A; Insulin-like growth factor-1; Insulin-like growth factor binding proteins; Atherosclerosis; Mexico.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )